Europe Colorectal Cancer Diagnostics Market - Industry Trends and Forecast to 2030

List of Tables

The Europe colorectal cancer diagnostics market is expected to reach USD 1,765.81 million by 2030 from USD 975.02 million in 2022, growing at a CAGR of 7.7% in the forecast period of 2023 to 2030.

Market Segmentation

Europe Colorectal Cancer Diagnostics Market, By Product Type (Instruments and Consumables & Accessories), Test Type (Stool Examination, Blood Test, Imaging Test, Tumor Markers, Biopsy and Others), Stages (Stage 0, Stage I, Stage II, Stage III and Stage IV), Cancer Type (Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors, and Others), Age Group (Geriatric, Adults and Pediatric), End User (Hospital, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgical Centers, Academic Institutes, and Others), Country (Germany, France, U.K., Italy, Spain, Russia, Turkey, Netherlands, Belgium, Switzerland, Rest of Europe) - Industry Trends and Forecast to 2030.

Overview of Europe Colorectal Cancer Diagnostics Market Dynamics

Driver
Growing prevalence of colorectal cancer
Restraint
Stringent regulatory policies
Opportunity
Rise in healthcare expenditure for cancer diagnosis and treatment

Market Players

Some of the key market players operating in the Europe colorectal cancer diagnostics market are
F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific, Inc.
QIAGEN
Abbott
Siemens Healthcare GmbH
Merck KGAA
Hologic, Inc.
Agilent Technologies, Inc.
Illumina, Inc.
Myriad Genetics, Inc.
Quest Diagnostics Incorporated.
Bio-Rad Laboratories, Inc.
Koninklijke Philips N.V.
BD
Time Medical Holding
PlexBio
Neusoft Corporation
BioFire Diagnostics
MinFound Medical Systems Co., Ltd
Medonica Co. LTD
CANON MEDICAL SYSTEMS CORPORATION

1 INTRODUCTION 20

1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 OVERVIEW OF THE EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET 20
1.4 LIMITATIONS 22
1.5 MARKETS COVERED 22

2 MARKET SEGMENTATION 25

2.1 MARKETS COVERED 25
2.2 GEOGRAPHICAL SCOPE 26
2.3 YEARS CONSIDERED FOR THE STUDY 27
2.4 CURRENCY AND PRICING 27
2.5 DBMR TRIPOD DATA VALIDATION MODEL 28
2.6 MULTIVARIATE MODELLING 31
2.7 PRODUCT TYPE LIFELINE CURVE 31
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 32
2.9 DBMR MARKET POSITION GRID 33
2.10 MARKET END USER COVERAGE GRID 34
2.11 VENDOR SHARE ANALYSIS 35
2.12 SECONDARY SOURCES 36
2.13 ASSUMPTIONS 36

3 EXECUTIVE SUMMARY 37

4 PREMIUM INSIGHTS 40

4.1 PORTER'S FIVE FORCES 42
4.2 PESTEL ANALYSIS 43

5 INDUSTRY INSIGHTS: 44

6 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, REGULATIONS 45

6.1 REGULATORY SCENARIO IN THE GERMANY 45
6.2 REGULATORY SCENARIO IN FRANCE 45
6.3 REGULATORY SCENARIO IN RUSSIA 46
6.4 REGULATORY SCENARIO IN ITALY 46

7 MARKET OVERVIEW 47

7.1 DRIVERS 49
- 7.1.1 GROWING PREVALENCE OF COLORECTAL CANCER 49
- 7.1.2 RISE IN THE NUMBER OF PATIENTS SUFFERING FROM DIVERTICULITIS AND ULCERATIVE COLITIS. 49
- 7.1.3 RISING PREFERENCE FOR PREVENTIVE HEALTH CHECK-UPS 49
7.2 RESTRAINTS 50
- 7.2.1 STRINGENT REGULATORY POLICIES 50
- 7.2.2 HIGH COST FOR THE COLORECTAL CANCER TREATMENTS. 51
7.3 OPPORTUNITIES 51
- 7.3.1 RISE IN HEALTHCARE EXPENDITURE FOR CANCER DIAGNOSIS AND TREATMENT 51
- 7.3.2 GOVERNMENT INITIATIVES TOWARD CANCER DIAGNOSTICS 52
- 7.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 53
7.4 CHALLENGES 53
- 7.4.1 INCREASED COST, SAFETY, AND CONVENIENCE ISSUES 53
- 7.4.2 LACK OF SKILLED AND CERTIFIED PROFESSIONALS 54

8 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE 55

8.1 OVERVIEW 56
8.2 INSTRUMENTS 58
- 8.2.1 PATHOLOGY-BASED INSTRUMENTS 59
  - 8.2.1.1 PCR INSTRUMENTS 60
  - 8.2.1.2 SLIDE STAINING SYSTEMS 60
  - 8.2.1.3 TISSUE PROCESSING SYSTEMS 60
  - 8.2.1.4 CELL PROCESSORS 60
  - 8.2.1.5 OTHER PATHOLOGY-BASED INSTRUMENTS 60
- 8.2.2 IMAGING INSTRUMENTS 61
  - 8.2.2.1 ULTRASOUND SYSTEMS 61
  - 8.2.2.2 CT SYSTEMS 61
  - 8.2.2.3 MRI SYSTEMS 61
  - 8.2.2.4 OTHERS 61
- 8.2.3 BIOPSY INSTRUMENTS 61
- 8.2.4 OTHERS 62
8.3 CONSUMABLES & ACCESSORIES 62
- 8.3.1 KITS 63
  - 8.3.1.1 PCR KITS 63
  - 8.3.1.2 DNA POLYMERASE KITS 63
  - 8.3.1.3 NUCLEIC ACID ISOLATION KITS 63
  - 8.3.1.4 OTHERS 63
- 8.3.2 REAGENTS 64
  - 8.3.2.1 ASSAYS 64
  - 8.3.2.2 BUFFERS 64
  - 8.3.2.3 PRIMERS 64
  - 8.3.2.4 OTHERS 64
- 8.3.3 OTHER CONSUMABLES 64

9 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE 65

9.1 OVERVIEW 66
9.2 STOOL EXAMINATION 68
9.3 BLOOD TEST 69
- 9.3.1 COMPLETE BLOOD COUNT (CBC) 70
- 9.3.2 TUMOR MARKER TEST 70
- 9.3.3 LIVER ENZYME BLOOD TEST 70
9.4 IMAGING TEST 70
- 9.4.1 COMPUTED TOMOGRAPHY (CT) SCAN 71
- 9.4.2 MRI 71
- 9.4.3 ULTRASOUND 71
- 9.4.4 POSITION EMISSION TOMOGRAPHY (PET) 71
- 9.4.5 OTHERS 71
9.5 TUMOR MARKERS 72
- 9.5.1 CARCINOEMBRYONIC ANTIGEN (CEA) 72
- 9.5.2 CA19-9 BIOMARKER TEST 72
- 9.5.3 CA 50 MARKER TEST 73
- 9.5.4 OTHERS 73
9.6 BIOPSY 73
9.7 OTHERS 73

10 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES 74

10.1 OVERVIEW 75
10.2 STAGE III 77
10.3 STAGE IV 78
10.4 STAGE II 78
10.5 STAGE I 79
10.6 STAGE 0 79

11 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP 80

11.1 OVERVIEW 81
11.2 GERIATRIC 83
11.3 ADULTS 84
11.4 PEDIATRIC 84

12 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE 85

12.1 OVERVIEW 86
12.2 ADENOCARCINOMA 88
12.3 COLORECTAL LYMPHOMA 89
12.4 GASTROINTESTINAL STROMAL TUMORS 89
12.5 CARCINOID TUMORS 90
12.6 OTHERS 90

13 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER 91

13.1 OVERVIEW 92
13.2 HOSPITALS 95
13.3 DIAGNOSTIC CENTERS 95
13.4 CANCER RESEARCH CENTERS 95
13.5 AMBULATORY SURGICAL CENTERS 96
13.6 ACADEMIC INSTITUTES 96
13.7 OTHERS 96

14 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, BY COUNTRY 98

14.1 EUROPE 98
- 14.1.1 GERMANY 103
- 14.1.2 FRANCE 108
- 14.1.3 U.K. 113
- 14.1.4 ITALY 118
- 14.1.5 SPAIN 123
- 14.1.6 RUSSIA 128
- 14.1.7 TURKEY 133
- 14.1.8 NETHERLANDS 138
- 14.1.9 BELGIUM 143
- 14.1.10 SWITZERLAND 148
- 14.1.11 REST OF EUROPE 153

15 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, COMPANY LANDSCAPE 154

15.1 COMPANY SHARE ANALYSIS: EUROPE 154

16 SWOT ANALYSIS 155

17 COMPANY PROFILES 156

17.1 F. HOFFMANN- LA ROCHE LTD 156
- 17.1.1 COMPANY SNAPSHOT 156
- 17.1.2 REVENUE ANALYSIS 156
- 17.1.3 PRODUCT PORTFOLIO 157
- 17.1.4 RECENT DEVELOPMENT 157
17.2 KONINKLIJKE PHILIPS N.V. 158
- 17.2.1 COMPANY SNAPSHOT 158
- 17.2.2 REVENUE ANALYSIS 158
- 17.2.3 PRODUCT PORTFOLIO 159
- 17.2.4 RECENT DEVELOPMENT 159
17.3 THERMO FISHER SCIENTIFIC INC. 160
- 17.3.1 COMPANY SNAPSHOT 160
- 17.3.2 REVENUE ANALYSIS 160
- 17.3.3 PRODUCT PORTFOLIO 160
- 17.3.4 RECENT DEVELOPMENT 161
17.4 ILLUMINA, INC. 162
- 17.4.1 COMPANY SNAPSHOT 162
- 17.4.2 REVENUE ANALYSIS 162
- 17.4.3 PRODUCT PORTFOLIO 163
- 17.4.4 RECENT DEVELOPMENT 163
17.5 QUEST DIAGNOSTICS INCORPORATED 164
- 17.5.1 COMPANY SNAPSHOT 164
- 17.5.2 REVENUE ANALYSIS 164
- 17.5.3 PRODUCT PORTFOLIO 165
- 17.5.4 RECENT DEVELOPMENT 165
17.6 ABBOTT 166
- 17.6.1 COMPANY SNAPSHOT 166
- 17.6.2 REVENUE ANALYSIS 166
- 17.6.3 PRODUCT PORTFOLIO 167
- 17.6.4 RECENT DEVELOPMENT 167
17.7 AGILENT TECHNOLOGIES, INC. 168
- 17.7.1 COMPANY SNAPSHOT 168
- 17.7.2 REVENUE ANALYSIS 168
- 17.7.3 PRODUCT PORTFOLIO 169
- 17.7.4 RECENT DEVELOPMENT 169
17.8 BD 170
- 17.8.1 COMPANY SNAPSHOT 170
- 17.8.2 REVENUE ANALYSIS 170
- 17.8.3 PRODUCT PORTFOLIO 171
- 17.8.4 RECENT DEVELOPMENT 171
17.9 BIOFIRE DIAGNOSTICS 172
- 17.9.1 COMPANY SNAPSHOT 172
- 17.9.2 REVENUE ANALYSIS 172
- 17.9.3 PRODUCT PORTFOLIO 173
- 17.9.4 RECENT DEVELOPMENT 173
17.10 BIO-RAD LABORATORIES, INC. 174
- 17.10.1 COMPANY SNAPSHOT 174
- 17.10.2 REVENUE ANALYSIS 174
- 17.10.3 PRODUCT PORTFOLIO 175
- 17.10.4 RECENT DEVELOPMENT 175
17.11 CANON MEDICAL SYSTEMS CORPORATION. 176
- 17.11.1 COMPANY SNAPSHOT 176
- 17.11.2 REVENUE ANALYSIS 176
- 17.11.3 PRODUCT PORTFOLIO 177
- 17.11.4 RECENT DEVELOPMENT 177
17.12 FONAR CORP. 178
- 17.12.1 COMPANY SNAPSHOT 178
- 17.12.2 REVENUE ANALYSIS 178
- 17.12.3 PRODUCT PORTFOLIO 179
- 17.12.4 RECENT DEVELOPMENT 179
17.13 FUJIFILM CORPORATION 180
- 17.13.1 COMPANY SNAPSHOT 180
- 17.13.2 REVENUE ANALYSIS 180
- 17.13.3 PRODUCT PORTFOLIO 181
- 17.13.4 RECENT DEVELOPMENT 181
17.14 GE HEALTHCARE. 182
- 17.14.1 COMPANY SNAPSHOT 182
- 17.14.2 REVENUE ANALYSIS 182
- 17.14.3 PRODUCT PORTFOLIO 183
- 17.14.4 RECENT DEVELOPMENT 183
17.15 HOLOGIC, INC. 184
- 17.15.1 COMPANY SNAPSHOT 184
- 17.15.2 REVENUE ANALYSIS 184
- 17.15.3 PRODUCT PORTFOLIO 184
- 17.15.4 RECENT DEVELOPMENT 185
17.16 MEDONICA CO. LTD 186
- 17.16.1 COMPANY SNAPSHOT 186
- 17.16.2 PRODUCT PORTFOLIO 186
- 17.16.3 RECENT DEVELOPMENT 186
17.17 MERCK KGAA 187
- 17.17.1 COMPANY SNAPSHOT 187
- 17.17.2 REVENUE ANALYSIS 187
- 17.17.3 PRODUCT PORTFOLIO 187
- 17.17.4 RECENT DEVELOPMENT 188

17.18 MINFOUND MEDICAL SYSTEMS CO., LTD 189
- 17.18.1 COMPANY SNAPSHOT 189
- 17.18.2 PRODUCT PORTFOLIO 189
- 17.18.3 RECENT DEVELOPMENT 190
17.19 MYRIAD GENETICS, INC. 191
- 17.19.1 COMPANY SNAPSHOT 191
- 17.19.2 REVENUE ANALYSIS 191
- 17.19.3 PRODUCT PORTFOLIO 192
- 17.19.4 RECENT DEVELOPMENT 192
17.20 NEUSOFT CORPORATION 193
- 17.20.1 COMPANY SNAPSHOT 193
- 17.20.2 REVENUE ANALYSIS 193
- 17.20.3 PRODUCT PORTFOLIO 194
- 17.20.4 RECENT DEVELOPMENT 194
17.21 PLEXBIO 195
- 17.21.1 COMPANY SNAPSHOT 195
- 17.21.2 PRODUCT PORTFOLIO 195
- 17.21.3 RECENT DEVELOPMENT 195
17.22 QIAGEN 196
- 17.22.1 COMPANY SNAPSHOT 196
- 17.22.2 REVENUE ANALYSIS 196
- 17.22.3 PRODUCT PORTFOLIO 197
- 17.22.4 RECENT DEVELOPMENT 197
17.23 SIEMENS HEALTHCARE GMBH 198
- 17.23.1 COMPANY SNAPSHOT 198
- 17.23.2 REVENUE ANALYSIS 198
- 17.23.3 PRODUCT PORTFOLIO 199
- 17.23.4 RECENT DEVELOPMENT 199
17.24 STERNMED GMBH 200
- 17.24.1 COMPANY SNAPSHOT 200
- 17.24.2 PRODUCT PORTFOLIO 200
- 17.24.3 RECENT DEVELOPMENT 200

18 QUESTIONNAIRE 201

19 RELATED REPORTS 205

LIST OF TABLES

TABLE 1 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 58
TABLE 2 EUROPE INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 59
TABLE 3 EUROPE PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 60
TABLE 4 EUROPE IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 61
TABLE 5 EUROPE CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 62
TABLE 6 EUROPE KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 63
TABLE 7 EUROPE REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 64
TABLE 8 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 68
TABLE 9 EUROPE BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 70
TABLE 10 EUROPE IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 71
TABLE 11 EUROPE TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 72
TABLE 12 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 77
TABLE 13 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 83
TABLE 14 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 88
TABLE 15 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 94
TABLE 16 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 102
TABLE 17 GERMANY COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 103
TABLE 18 GERMANY INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 103
TABLE 19 GERMANY PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 103
TABLE 20 GERMANY IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 104
TABLE 21 GERMANY CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 104
TABLE 22 GERMANY KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 104
TABLE 23 GERMANY REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 104
TABLE 24 GERMANY COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 105
TABLE 25 GERMANY BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 105
TABLE 26 GERMANY IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 105
TABLE 27 GERMANY TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 106
TABLE 28 GERMANY COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 106
TABLE 29 GERMANY COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 106
TABLE 30 GERMANY COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 106
TABLE 31 GERMANY COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 107
TABLE 32 FRANCE COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 108
TABLE 33 FRANCE INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 108
TABLE 34 FRANCE PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 108
TABLE 35 FRANCE IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 109
TABLE 36 FRANCE CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 109
TABLE 37 FRANCE KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 109
TABLE 38 FRANCE REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 109
TABLE 39 FRANCE COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 110
TABLE 40 FRANCE BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 110
TABLE 41 FRANCE IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 110
TABLE 42 FRANCE TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 111
TABLE 43 FRANCE COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 111
TABLE 44 FRANCE COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 111
TABLE 45 FRANCE COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 112
TABLE 46 FRANCE COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 112
TABLE 47 U.K. COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 113
TABLE 48 U.K. INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 113
TABLE 49 U.K. PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 113
TABLE 50 U.K. IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 114
TABLE 51 U.K. CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 114
TABLE 52 U.K. KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 114
TABLE 53 U.K. REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 114
TABLE 54 U.K. COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 115
TABLE 55 U.K. BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 115
TABLE 56 U.K. IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 115
TABLE 57 U.K. TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 116
TABLE 58 U.K. COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 116
TABLE 59 U.K. COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 116
TABLE 60 U.K. COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 117
TABLE 61 U.K. COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 117
TABLE 62 ITALY COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 118
TABLE 63 ITALY INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 118
TABLE 64 ITALY PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 118
TABLE 65 ITALY IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 119
TABLE 66 ITALY CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 119
TABLE 67 ITALY KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 119
TABLE 68 ITALY REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 119
TABLE 69 ITALY COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 120
TABLE 70 ITALY BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 120
TABLE 71 ITALY IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 120
TABLE 72 ITALY TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 121
TABLE 73 ITALY COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 121
TABLE 74 ITALY COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 121
TABLE 75 ITALY COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 122
TABLE 76 ITALY COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 122
TABLE 77 SPAIN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 123
TABLE 78 SPAIN INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 123
TABLE 79 SPAIN PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 123
TABLE 80 SPAIN IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
TABLE 81 SPAIN CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
TABLE 82 SPAIN KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
TABLE 83 SPAIN REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
TABLE 84 SPAIN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 125
TABLE 85 SPAIN BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 125
TABLE 86 SPAIN IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 125
TABLE 87 SPAIN TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 126
TABLE 88 SPAIN COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 126
TABLE 89 SPAIN COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 126
TABLE 90 SPAIN COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 127
TABLE 91 SPAIN COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 127
TABLE 92 RUSSIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 128
TABLE 93 RUSSIA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 128
TABLE 94 RUSSIA PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 128
TABLE 95 RUSSIA IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 129
TABLE 96 RUSSIA CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 129
TABLE 97 RUSSIA KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 129
TABLE 98 RUSSIA REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 129
TABLE 99 RUSSIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 130
TABLE 100 RUSSIA BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 130
TABLE 101 RUSSIA IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 130
TABLE 102 RUSSIA TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 131
TABLE 103 RUSSIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 131
TABLE 104 RUSSIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 131
TABLE 105 RUSSIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 132
TABLE 106 RUSSIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 132
TABLE 107 TURKEY COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 133
TABLE 108 TURKEY INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 133
TABLE 109 TURKEY PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 133
TABLE 110 TURKEY IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
TABLE 111 TURKEY CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
TABLE 112 TURKEY KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
TABLE 113 TURKEY REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
TABLE 114 TURKEY COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 135
TABLE 115 TURKEY BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 135
TABLE 116 TURKEY IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 135
TABLE 117 TURKEY TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 136
TABLE 118 TURKEY COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 136
TABLE 119 TURKEY COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 136
TABLE 120 TURKEY COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 137
TABLE 121 TURKEY COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 137
TABLE 122 NETHERLANDS COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 138
TABLE 123 NETHERLANDS INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 138
TABLE 124 NETHERLANDS PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 138
TABLE 125 NETHERLANDS IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 139
TABLE 126 NETHERLANDS CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 139
TABLE 127 NETHERLANDS KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 139
TABLE 128 NETHERLANDS REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 139
TABLE 129 NETHERLANDS COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 140
TABLE 130 NETHERLANDS BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 140
TABLE 131 NETHERLANDS IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 140
TABLE 132 NETHERLANDS TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 141
TABLE 133 NETHERLANDS COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 141
TABLE 134 NETHERLANDS COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 141
TABLE 135 NETHERLANDS COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 142
TABLE 136 NETHERLANDS COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 142
TABLE 137 BELGIUM COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 143
TABLE 138 BELGIUM INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 143
TABLE 139 BELGIUM PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 143
TABLE 140 BELGIUM IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 144
TABLE 141 BELGIUM CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 144
TABLE 142 BELGIUM KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 144
TABLE 143 BELGIUM REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 144
TABLE 144 BELGIUM COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 145
TABLE 145 BELGIUM BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 145
TABLE 146 BELGIUM IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 145
TABLE 147 BELGIUM TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 146
TABLE 148 BELGIUM COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 146
TABLE 149 BELGIUM COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 146
TABLE 150 BELGIUM COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 147
TABLE 151 BELGIUM COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 147
TABLE 152 SWITZERLAND COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 148
TABLE 153 SWITZERLAND INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 148
TABLE 154 SWITZERLAND PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 148
TABLE 155 SWITZERLAND IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 149
TABLE 156 SWITZERLAND CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 149
TABLE 157 SWITZERLAND KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 149
TABLE 158 SWITZERLAND REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 150
TABLE 159 SWITZERLAND COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 150
TABLE 160 SWITZERLAND BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 150
TABLE 161 SWITZERLAND IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 151
TABLE 162 SWITZERLAND TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 151
TABLE 163 SWITZERLAND COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 151
TABLE 164 SWITZERLAND COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 152
TABLE 165 SWITZERLAND COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 152
TABLE 166 SWITZERLAND COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 152
TABLE 167 REST OF EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 153

LIST OF FIGURES

FIGURE 1 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: SEGMENTATION 25
FIGURE 2 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: DATA TRIANGULATION 28
FIGURE 3 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: DROC ANALYSIS 29
FIGURE 4 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 30
FIGURE 5 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS 30
FIGURE 6 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS 32
FIGURE 7 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID 33
FIGURE 8 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: MARKET END USER COVERAGE GRID 34
FIGURE 9 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS 35
FIGURE 10 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: SEGMENTATION 39
FIGURE 11 THE INCREASE IN THE AWARENESS ABOUT COLORECTAL CANCER IS EXPECTED TO DRIVE THE EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET GROWTH IN THE FORECAST PERIOD 40
FIGURE 12 THE INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET IN 2023 & 2030 40
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET 48
FIGURE 14 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2022 56
FIGURE 15 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION) 57
FIGURE 16 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 57
FIGURE 17 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, LIFELINE CURVE 58
FIGURE 18 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2022 66
FIGURE 19 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION) 67
FIGURE 20 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY TEST TYPE, CAGR (2023-2030) 67
FIGURE 21 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY TEST TYPE, LIFELINE CURVE 68
FIGURE 22 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, 2022 75
FIGURE 23 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, 2023-2030 (USD MILLION) 76
FIGURE 24 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, CAGR (2023-2030) 76
FIGURE 25 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, LIFELINE CURVE 77
FIGURE 26 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2022 81
FIGURE 27 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2023-2030 (USD MILLION) 82
FIGURE 28 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY AGE GROUP, CAGR (2023-2030) 82
FIGURE 29 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY AGE GROUP, LIFELINE CURVE 83
FIGURE 30 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2022 86
FIGURE 31 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2023-2030 (USD MILLION) 87
FIGURE 32 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, CAGR (2023-2030) 87
FIGURE 33 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, LIFELINE CURVE 88
FIGURE 34 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY END USER, 2022 92
FIGURE 35 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY END USER, 2023-2030 (USD MILLION) 93
FIGURE 36 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY END USER, CAGR (2023-2030) 93
FIGURE 37 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE 94
FIGURE 38 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 99
FIGURE 39 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022) 100
FIGURE 40 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 100
FIGURE 41 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030) 101
FIGURE 42 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: PRODUCT TYPE (2023-2030) 101
FIGURE 43 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%) 154